Lv1
46 积分 2024-04-30 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
19小时前
待确认
Correspondence on: ‘CD19-CAR T-cell therapy induces deep tissue depletion of B cells’ by Tur et al
20小时前
求助中
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
21小时前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
15天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
16天前
已完结
B-cell depletion in autoimmune diseases
16天前
已完结
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint Resistance
20天前
已完结
The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards
21天前
已完结
T-cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial
1个月前
已完结
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel
3个月前
已完结
皖公网安备34019202002308
